Is There any Additional Benefit of Multiple Doses of Tocilizumab in COVID-19 Patients?

Many patients with coronavirus disease 2019 (COVID-19) have a hyperactive immune response (cytokine storm) which has been incriminated in multiorgan dysfunction (MOD). Interleukin-6 (IL-6) and granulocyte-macrophage colony-stimulating factor (GM-CSF) are the key cytokines involved in mediating syste...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Cureus
Main Authors: Mughal, Mohsin S, Kaur, Ikwinder, Kakadia, Mili, Wang, Chang, Alhashemi, Reem, Salloum, Rafah, Ricca, Anthony, Granet, Kenneth
Formato: Artigo
Idioma:Inglês
Publicado: Cureus 2020
Assuntos:
Internal Medicine
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7815303/
https://ncbi.nlm.nih.gov/pubmed/33489621
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7759/cureus.12214
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares